Xeris Biopharma Holdings Inc (XERS)

Other Income/Expenses (Net)

-$36.27M

Quarterly · Period ending: · USD

XERS logo

XERS Other Income/Expenses (Net)

Latest reported-$36.27M
XERS Quarterly Other Income/Expenses (Net) ($0.00 → -$36.27M)
High-resolution chart · PNG

XERS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-36,274,000
-5,682,000
-5,692,000
-6,110,000
-6,410,000
-6,130,000
-6,792,000
-6,169,000
-6,069,000
-4,428,000
-3,785,000
-7,614,000
-4,538,000
-3,557,000
1,902,000
-3,390,000
-7,608,000
-5,048,000
-2,519,000
-1,651,000
-1,728,000
-1,671,000
-2,514,000
-2,256,000
-2,004,000
-930,000
-739,000
-2,754,000
-325,000
160,000
-105,000
176,000
-630,000
-177,000
63,000
45,000
-33,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.